Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters











Database
Language
Publication year range
1.
Diabetes Res Clin Pract ; 159: 107661, 2020 Jan.
Article in English | MEDLINE | ID: mdl-30880091

ABSTRACT

Clinical studies showed that dextran sulfate sodium (DSS) alleviates stroke, diabetic retinopathy and hypercholesterolemia, yet its mechanism of action was unrevealed. This study show that DSS reduces hyperglycemia, plasma insulin and enhances glucose utilization by attenuating ROS production, suggesting a novel therapeutic use of DSS in diabetes and its complication.


Subject(s)
Dextran Sulfate/therapeutic use , Diabetes Mellitus/drug therapy , Hypoglycemic Agents/therapeutic use , Animals , Dextran Sulfate/pharmacology , Humans , Hypoglycemic Agents/pharmacology , Male , Mice
SELECTION OF CITATIONS
SEARCH DETAIL